Omada Health, Inc. Deferred Offering Costs
Omada Health, Inc. (OMDA) had Deferred Offering Costs of $0 as of 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2026-03-06
- 2025-12-31: Deferred Offering Costs $0.00.
- 2025-06-09: Deferred Offering Costs $9.00M.
- 2024-12-31: Deferred Offering Costs $4.80M.
| Period end | Deferred Offering Costs |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-06 |
| 2025-06-09 | $9.00M 10-K · filed 2026-03-06 |
| 2024-12-31 | $4.80M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |